Vident Advisory’s Lifestance Health LFST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$284K Buy
44,622
+7,160
+19% +$49.8K ﹤0.01% 1528
2025
Q4
$264K Buy
37,462
+22,406
+149% +$135K ﹤0.01% 1424
2025
Q3
$82.8K Sell
15,056
-6,676
-31% -$32.7K ﹤0.01% 1605
2025
Q2
$112K Buy
21,732
+2,447
+13% +$14.7K ﹤0.01% 1562
2025
Q1
$128K Sell
19,285
-1,941
-9% -$14.8K ﹤0.01% 1485
2024
Q4
$156K Buy
+21,226
New +$152K ﹤0.01% 1375
2024
Q3
Sell
-10,229
Closed -$50.2K 1480
2024
Q2
$50.2K Buy
+10,229
New +$61.7K ﹤0.01% 1387

Other funds holding LFST

Vident Advisory's LFST Position: Q1 2026 in Review

Vident Advisory increased its Lifestance Health (LFST) stake by 19% in Q1 2026, buying an estimated $49.8K and bringing the position to 44,622 shares worth $284K. The position accounts for ﹤0.01% of the portfolio, ranked #1528.

Vident Advisory first reported a position in LFST in Q2 2024 and has held it in 7 quarters since. 228 funds tracked by Wall St. Rank hold LFST as of Q1 2026.

  • Vident Advisory held 44,622 shares of Lifestance Health worth $284K as of Q1 2026.
  • Vident Advisory bought 7,160 Lifestance Health shares in Q1 2026, an estimated $49.8K.
  • Lifestance Health made up ﹤0.01% of Vident Advisory's portfolio in Q1 2026, its #1528 holding.
  • Vident Advisory first reported a position in Lifestance Health in Q2 2024 and has held it in 7 quarters since.
  • 228 funds tracked by Wall St. Rank held Lifestance Health as of Q1 2026.

Based on Vident Advisory's 13F filing for Q1 2026, filed 15 May 2026.